Mind-Reading chip: neuralink Robot-Implants brain device for speech

NCT ID NCT07224256

Recruiting now Disease control Sponsor: Neuralink Corp Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

Neuralink is testing a brain-computer interface called the N1 Implant, placed by a robot, to help people with severe paralysis communicate. The study will enroll 6 adults with conditions like ALS or spinal cord injury who cannot speak or use their hands well. The main goal is to check safety, but researchers will also see if the device can translate brain signals into communication.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: N1 Implant (brain-computer interface device) and R1 Robot (surgical implantation robot)
What this could lead to: If successful, this could provide a new way for people with severe paralysis to communicate using only their thoughts.
What could go wrong: This is a very early, small study (6 people) focused on safety. The device requires brain surgery, which carries risks like infection or bleeding. It may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

amyotrophic lateral sclerosis Dysarthria lateral sclerosis palsy quadriplegia Speech spinal cord injury stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AMYOTROPHIC LATERAL SCLEROSIS CERVICAL SPINAL CORD INJURY QUADRIPLEGIA QUADRIPLEGIA/TETRAPLEGIA STROKE TETRAPLEGIA/TETRAPARESIS TETRAPLEGIC; PARALYSIS

Contacts and locations

Locations

The University of Texas Southwestern Medical Center
RECRUITING

Dallas, Texas, 75390, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.